Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

clinical trial

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00259857

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2008-03-01
P4135maximum age15
P1050medical conditionosteoporosisQ165328
P2899minimum age5
P1132number of participants22
P4844research interventioncalcium oxalateQ412399
(5R)-24,25-Dihydroxyvitamin DQ27161510
alendronate sodium trihydrate / colecalciferolQ28859601
P6153research siteMedical University of South CarolinaQ6806451
P580start time2003-10-01
P8363study typeinterventional studyQ78089383
P1476titleA Randomized, Double-Blind, Placebo-Controlled, Prospective, Cross-Over Phase II Clinical Trial to Determine the Safety and Efficacy of Alendronate (Fosamax) in Juvenile Osteoporosis (IND#60,017)

Search more.